Skip to main content

BioCryst Pharmaceuticals, Inc. - Common Stock (NQ: BCRX )

7.570 +0.180 (+2.44%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist

Other Filings

Form 425
Source: SEC/Edgar
April 09, 2018
Form CT ORDER
Source: SEC/Edgar
April 05, 2018
Form 425
Source: SEC/Edgar
April 01, 2018
Form SC 13D
Source: SEC/Edgar
April 01, 2018
Form 425
Source: SEC/Edgar
April 01, 2018
Form 425
Source: SEC/Edgar
April 01, 2018
Form 425
Source: SEC/Edgar
April 01, 2018
Form DEFM14A
Source: SEC/Edgar
March 28, 2018
Form 10-K/A
Source: SEC/Edgar
March 26, 2018
Form 425
Source: SEC/Edgar
March 21, 2018
Form 425
Source: SEC/Edgar
March 21, 2018
Form 425
Source: SEC/Edgar
March 07, 2018
Form 425
Source: SEC/Edgar
March 06, 2018
Form 425
Source: SEC/Edgar
February 19, 2018
Form SC 13D
Source: SEC/Edgar
February 15, 2018
Form SC 13G/A
Source: SEC/Edgar
February 13, 2018
Form SC 13G/A
Source: SEC/Edgar
February 13, 2018
Form SC 13G
Source: SEC/Edgar
February 13, 2018
Form SC 13G/A
Source: SEC/Edgar
February 13, 2018
Form SC 13G/A
Source: SEC/Edgar
February 13, 2018
Form SC 13G/A
Source: SEC/Edgar
February 12, 2018
Form SC 13G
Source: SEC/Edgar
February 11, 2018
Form SC 13G
Source: SEC/Edgar
February 07, 2018
Form SC 13G/A
Source: SEC/Edgar
January 28, 2018
Form 425
Source: SEC/Edgar
January 22, 2018
Form 425
Source: SEC/Edgar
January 21, 2018
Form 425
Source: SEC/Edgar
January 21, 2018
Form 425
Source: SEC/Edgar
January 21, 2018
Form 425
Source: SEC/Edgar
January 21, 2018
Form 425
Source: SEC/Edgar
January 21, 2018
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.